Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Omeros Corp (NASDAQ:OMER)

11.30
Delayed Data
As of 3:59pm ET
 -0.22 / -1.91%
Today’s Change
8.90
Today|||52-Week Range
30.23
-28.16%
Year-to-Date
More Picks for a Rough Market
May 19 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close11.52
Today’s open11.55
Day’s range11.12 - 11.55
Volume138,082
Average volume (3 months)406,166
Market cap$450.8M
Dividend yield--
Data as of 3:59pm ET, 05/26/2016

Growth & Valuation

Earnings growth (last year)+9.91%
Earnings growth (this year)+12.00%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)+2,406.31%
P/E ratioNM
Price/Sales43.74
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ENTAEnanta Pharmaceutica...-0.60-2.52%
XNPTXenoport Inc+0.01+0.14%
RPTPRaptor Pharmaceutica...-0.09-1.75%
OTICOtonomy Inc-0.25-1.73%
Data as of 3:59pm ET, 05/26/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$13.5M
Annual profit (last year)-$75.1M
Net profit margin-555.90%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
Senior Director-
Finance
David R. Toll
Corporate headquarters
Seattle, Washington

Forecasts

Partner Offers

Search for Jobs